Cite
HARVARD Citation
Colleoni, M. et al. (2018). Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Lancet oncology. 19 (1), pp. 127-138. [Online].